Page 82 - Sohini Das

DRL launches DRDO drug 2-DG to treat moderate to severe Covid patients

2-DG was developed by the Institute of Nuclear Medicine & Allied Sciences (INMAS), a laboratory of the Defence Research and Development Organisation (DRDO), in collaboration with Dr Reddy's

Taken up Covishield travel issue at highest levels: Adar Poonawalla

Reports suggest India plans to take this matter of non-inclusion of Covishield in the list of approved vaccines for European Union (EU) 'Green Pass' up with the EU

Centre adds over 32,000 cold chain equipment since March last year

There are 37 state vaccine stores, 114 regional vaccine stores, 723 district vaccine stores and 28,268 sub-district vaccine stores

51% of Covid-19 vaccinations in May-June have been in rural centres

In terms of total Covid vaccinations by states, Uttar Pradesh, Maharastra, Rajasthan, West Bengal have fared strongly

Zydus Covid-19 vaccine doses may be out soon for adolescents: Govt

Says 1.35 bn doses will be available between Aug-Dec; 160 mn doses are expected between May and July

Covid-19 vaccination: Fear, myths & rumours inject vaccine hesitancy

Govts, NGOs and corporations try to get fence-sitters to take the jab

Not insisting on board seat; only an investor: Thyrocare's A Velumani

I am an investor, and not insisting on any board seat. I am selling my entire stake of 66 per cent, says Velumani

PharmEasy parent to acquire 66% stake in Thyrocare for Rs 4,546 cr

PharmEasy will retain the Thyrocare brand

Covid vaccine: Sputnik V may not be available in India for another 2 weeks

Around 3 million units of the first dose of the vaccine have landed in India, while the consignment of the second dose is expected by the end of this month.

Serum Institute starts Covovax production; govt expects 200 mn doses by Dec

India will allow entry of this vaccine once the USFDA approves it

Apollo's digital platform move may fuel consolidation, benefit consumers

Apollo will merge its online and offline pharmacy businesses (excluding hospital pharmacies) and telemedicine verticals into a single entity called Apollo HealthCo

Herd immunity is both mystical and mythical: NTAGI chairman N K Arora

Herd immunity works when immunised and unimmunised individuals are mixed in a true random process and around 80 per cent are immunised, said Arora

Private hospitals to order Covid-19 jabs on CoWin platform from July

Vaccine makers see logistics issues in distributing to smaller hospitals

Bharat Biotech's Covaxin shows over 77% efficacy in phase 3 trials

The vaccine has shown an efficacy rate of 93 per cent against severe disease and 60 per cent against asymptomatic Covid-19

Pfizer in the final stages to ink Covid-19 vaccine deal with Centre

Sources close to the developments had indicated earlier that the price for India could be below $10 per dose, or the lowest in the world

Covid-19 vaccination score tops 8 million as new rules take effect

Monday number 2.5 times the daily average

Full Covid-19 vaccination of adults will take 7 months if pace doubled

There are 865 million adults who require vaccination to meet the December target

Only 0.05% fully vaccinated healthcare workers got severe Covid: Fortis

Study covered over 16,000 healthcare workers across Fortis hospitals in India

Exploring windows to enhance shareholder value: Thyrocare Technologies

Thyrocare's market capitalisation is around Rs 6,916 crore. The deal thus could be for a shareholding in the firm

How Biological E could emerge as game changer in India's vaccine race

Company scales up its ambition after government advanced it Rs 1,500 crore for 300 million doses of its vaccine candidate.